Atlas Trials

An Extension Study of Duloxetine in Fibromyalgia (Extension of F1J-JE-HMGZ, NCT01552057)

Clinical trial NCT01621191 · COMPLETED

Trial details

NCT number
NCT01621191
Sponsor
Eli Lilly and Company
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Fibromyalgia
Start date
2012-06-01
Primary completion
2014-02-01
Enrollment
149

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.